Extracorporeal Membrane Oxygenation (ECMO) for Pediatric Respiratory Failure due to Respiratory Syncytial Virus Infection

Otto M González-Pardo*

Abstract

Extracorporeal membrane oxygenation (ECMO) is a useful therapeutic alternative in the management of refractory respiratory failure in children. ECMO is a therapy that since 1985 has shown to have a survival rate of 53% in this group, with survival rates in recent years of 63%, especially if the etiology is respiratory syncytial virus.